drugset / Trial / NCT00814216

Efficacy, Safety and Pharmacokinetics of QAV680 in Asthma Patients

NCT00814216

Phase 2 Completed 37 enrolled Novartis
RandomizedCrossoverQuadruple-blindTreatment

Summary

This study aims to study the efficacy (as measured by change in FEV1) and safety of two-week administration of oral QAV680 in the treatment of patients with asthma.'

Timeline

Start
2008-12
Primary completion
2009-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluticasone propionate Other / unclassified
Subject QAV680 Small molecule Oral

Indications